Millicom International Cellular S.A. Common Stock vs 22nd Century Group Inc — how do they compare? Millicom International Cellular S.A. Common Stock trades at $81.07 (market cap $13.49B), while 22nd Century Group Inc trades at $0.65 (market cap $464.52K). The key difference: Millicom International Cellular S.A. Common Stock is far larger — about 29040.7× 22nd Century Group Inc's market cap, and Millicom International Cellular S.A. Common Stock pays a 3.73% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Millicom International Cellular S.A. Common Stock for 0 Days and 22nd Century Group Inc for 33 Days on average.
| TIGO | XXII | |
|---|---|---|
Market Cap | $13.49B | $464.52K |
Volume | 1,314,537 | 16,668 |
Sector | Media | Consumer Staples |
52-Week High | $104.31 | $483.00 |
52-Week Low | $45.81 | $0.65 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $24.53B | -$3.84M |
Dividend Yield | 3.73% | — |
Signals from Pluang's Aura AI — not financial advice
TIGO trades at $79.54, down 0.92% on the day, with a neutral technical signal and key support at $79. The company reported strong 2025 results with $5.82B revenue and $1.32B net income, but 2026 earnings have missed expectations in two of the last three quarters. Recent news highlights its addition to Zacks' Strong Buy list and a consistent $0.75 quarterly dividend.
The stock offers a 12.9% upside to the consensus price target of $89.78, supported by solid profitability and cash flow, but faces risks from earnings volatility and high debt. Analyst sentiment is mixed with a Hold consensus, suggesting cautious optimism amid integration challenges from recent acquisitions.
XXII trades at $0.67, down 7.98% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.06 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives in France and Europe.
Despite analyst optimism (75% buy ratings with $1,240 price target), fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces significant execution risk in commercializing reduced-nicotine tobacco products while navigating regulatory timelines.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Millicom International Cellular S.A. operates telecommunications and digital services under the Tigo brand across Latin America, providing mobile, fiber broadband, and pay-TV services. The company also offers mobile financial services through its Tigo Money business.
Read more on TIGO →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →